A prospective, open-label, single arm study to evaluate the efficacy of LAFZ ETHNIC Bhringaraj & Amla Strengthening Anti-Hair Fall Herbal Shampoo in reducing the hair fall in healthy male or female volunteers

Believe Pte. Ltd.,0 个研究点目标入组 20 人开始时间: 待定最近更新: 2023年5月29日

试验速览

暂无简介。

•1. Willing to give informed consent.
•2. Healthy Indian male/female volunteer aged between 18-55 years (both inclusive)
•3. Must be able to adhere to the study visit schedule and other protocol requirements.
•4. Willing to complete the questionnaires.
•5. Subjects experiencing mild to moderate hair loss.
•6. Willing to avoid usage of his/her own hair oils, shampoo and other hair products for at least one week before commencement and during this study.

•1. Pregnancy or breast feeding.
•2. Inability to provide voluntary consent.
•3. Patients with pre-existing severe systemic disease necessitating long-term medication.
•4. Evidence of significant uncontrolled co-morbid disease which in the investigators opinion would jeopardize patient participation.
•5. History of cancer, including solid tumours, hematologic malignancies and carcinoma in situ
•6. On any medication or supplement for hair loss including finasteride, any other 5-alpha- reeducate inhibitors, minoxidil, steroids or hormonal products during the 3 months prior to study commencement.
•7. On any medication or supplement against dandruff including ketoconazole, Selenium sulfide, Salicylic acid, Pyrithione zinc etc during the 3 months prior to study commencement.
•8. History of hypersensitivity reactions.
•9. Recently undergone hair transplant surgery.
•10. Use of any anti-psychotic drugs for one week prior to Baseline.
•11. Use of any investigational medication within 4 weeks prior to start of study drug.

发起方

Believe Pte. Ltd.,